0000899243-23-000986.txt : 20230105
0000899243-23-000986.hdr.sgml : 20230105
20230105161517
ACCESSION NUMBER: 0000899243-23-000986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marango Jotin
CENTRAL INDEX KEY: 0001777513
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40287
FILM NUMBER: 23511462
MAIL ADDRESS:
STREET 1: C/O APTOSE BIOSCIENCES INC.
STREET 2: 251 CONSUMERS ROAD, SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ikena Oncology, Inc.
CENTRAL INDEX KEY: 0001835579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-343-8292
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
0
0001835579
Ikena Oncology, Inc.
IKNA
0001777513
Marango Jotin
C/O IKENA ONCOLOGY, INC.
645 SUMMER STREET, SUITE 101
BOSTON
MA
02210
0
1
0
0
CFO & Head of Corp. Dev.
Stock Option (Right to Buy)
2.62
2023-01-03
4
A
0
105000
0.00
A
2033-01-03
Common Stock
105000
105000
D
25% of the shares subject to this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter.
/s/ Mark Manfredi, as Attorney-in-Fact for Jotin Marango
2023-01-05